Genetic research for pancreatic cancer in Ashkenazi Jewish patients
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at genetic (DNA) factors related to pancreatic cancer. It may help researchers understand risks and find ways to improve prevention or treatment for people in the study population.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with pancreatic cancer
- You are of Ashkenazi Jewish descent
- You are part of the Columbia tissue bank/registry for high-risk individuals
- You can understand the study and give informed consent (or have a legal way to consent)
- You are 18 years old or older
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
This trial tests ways to screen people who have a family-passed (inherited) gene mutation linked to higher pancreatic cancer risk. The goal is to find pancreatic cancer earlier and improve how screening is done for people at increased risk.
This study looks at factors in the family and the environment that may be linked to pancreatic cancer. It includes people with pancreatic cancer and several types of pancreas-related conditions, as well as some healthy volunteers, and may help researchers understand who is at higher risk.
This study is a registry (a way to track health over time) for people with a strong family history or certain inherited genetic risks for pancreatic cancer. It may help doctors learn how best to monitor and protect high-risk people, and to see who benefits most from follow-up.
This study offers genetic testing to people at higher risk for pancreatic cancer, especially those with a family history or certain genetic changes. It aims to help you understand your risk and possibly catch cancer early.
This study looks at how a person’s genetic variations may relate to cancer-related weight loss (cachexia) in pancreatic cancer. It may help researchers better understand who is most at risk and guide future treatments.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.